Skip to Main Content

Paper Details

Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
J Clin Oncol
60
2020
Author NameAffiliation
Kim-Hien T DaoKnight Cancer Institute, Oregon Health & Science University
Jason GotlibStanford University School of Medicine/Stanford Cancer Institute
Michael W DeiningerUniversity of Utah, Huntsman Cancer Institute
Stephen T OhWashington University in St Louis
Jorge CortesUniversity of Texas MD Anderson Cancer Center
Robert H CollinsThe University of Texas Southwestern Medical Center
Hyunjung LeeKnight Cancer Institute, Oregon Health & Science University
Samantha L SavageKnight Cancer Institute, Oregon Health & Science University
Richard D PressOregon Health & Science University
Jennifer DunlapOregon Health & Science University
Julia E MaxsonKnight Cancer Institute, Oregon Health & Science University
Cristina E TognonKnight Cancer Institute, Oregon Health & Science University
Tara A MaceyKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerHoward Hughes Medical Institute
Jeffrey W TynerKnight Cancer Institute, Oregon Health & Science University
  • 1 - 16

Datasets

Release 1.2